Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 55Gastrointestinal 34Thoracic 31CNS 27Breast 15Tumor-Agnostic 9Dermatologic 9Head & Neck 8Sarcoma 4NET 2Gynecologic 2Endocrine 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neuroendocrine Tumors 1Neoplasm Metastasis 1Gastro-enteropancreatic neuroendocrine tumor 1Colorectal Neoplasms 1Anal Canal Carcinoma 1

Interventions

lutetium Lu 177 dotatate 15Magnetic Resonance Spectroscopy 9Everolimus 8gallium Ga 68 dotatate 6lanreotide 4cabozantinib 4Temozolomide 4Specimen Handling 4Nivolumab 4Lutetium-177 4Lutetium 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4surufatinib 3olaparib 3copper dotatate CU-64 3Somatostatin 3Injections 3Ga(III)-DOTATOC 3Fluorodeoxyglucose F18 3Cyclophosphamide 3Capecitabine 3pembrolizumab 2fludarabine phosphate 2fludarabine 2amino-acid, glucose, and electrolyte solution 2X-Rays 2Sunitinib 2Radiosurgery 2Octreotide 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Radiosurgery × NET × Clear all
NCT07150546 2026-03-02

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Emory University

Phase 1 Recruiting
15 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT02185443 2024-12-09

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

University of Sao Paulo

Phase 2 Recruiting
43 enrolled
EndocrineGastrointestinalNET

Anal Canal Carcinoma, Neoplasm Metastasis, Colorectal Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡